← Leaderboards
Patricia Yea Chu
Children'S Hosp Of Philadelphia
$99,106
Attributed
$99,106
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $91K · FY2024–25$100K$75K$50K$25K$0
'24
'25
Funding mix
By agency
NIH$99,106 · 1
By mechanism
F32$99,106 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Daniel Corwin$862,332
- Razzaghi Hanieh$555,151
- Regina M Myers$539,966
- Michelle Denburg$7,914,001
- Elizabeth G Salazar$160,052
Others in their field
Other Rising Stars on “Complex”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$58,129,860
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Maximilian Haeussler · University Of California Santa Cruz$13,899,136
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Jason Dickens · Duke University$12,259,409
Research focus
ComplexAccess Disparities17 Year OldAdolescentAdolescent And Young AdultAdultAffectAccelerationAge StratificationAgonistBiometryB-LymphocytesBody Weight DecreasedCardiovascular DiseasesCareer DevelopmentCell PhysiologyCharacteristicsClinical EpidemiologyClinical ResearchClinical TrialsCohortCompare EffectivenessComparison ControlComplications Of Diabetes Mellitus
Grant awards (2)
Real-world Effectiveness and Utilization of Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Type 2 Diabetes in Adolescents and Young Adults$8,118
F32 · FY2025 · DK · contact PI
Real-world Effectiveness and Utilization of Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Type 2 Diabetes in Adolescents and Young Adults$90,988
F32 · FY2024 · DK · contact PI